Home › Funds › Capital World Investors › MRNA
Capital World Investors position in MRNA
MODERNA INC · Health Care
Capital World Investors reported holding 22,638,960 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$4.36B, representing 0.53% of its reported portfolio and ranking #47 among its reported holdings. Capital World Investors has disclosed MRNA holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Capital World Investors's MRNA position evolved
Capital World Investors first disclosed a stake in MRNA in Q3 2023 at 3,967,731 shares (US$409.8M). The position peaked in Q3 2026 at 22,638,960 shares, worth US$4.36B. Across 8 filings, Capital World Investors increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 22,638,960 shares valued at US$4.36B — an increase of 361,964 shares quarter over quarter.. Notable position changes include a 46% increase in Q1 2026 (shares rose 38% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 3.97M | $409.83M | New |
| Q4 2023 | 3.63M | $360.94M | Reduce |
| Q1 2024 | 3.65M | $388.74M | Add |
| Q2 2024 | 3.67M | $435.48M | Add |
| Q4 2025 | 12.83M | $378.30M | New |
| Q1 2026 | 18.70M | $949.81M | Add |
| Q2 2026 | 22.28M | $1.56B | Add |
| Q3 2026 | 22.64M | $4.36B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 41 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Baillie Gifford & Co (US$2.20B), IMC-Chicago, LLC (US$590.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Fidelity Management & Research (FMR) 58.96M sh · $11.35B · Q3 2026
- Baillie Gifford & Co 11.44M sh · $2.20B · Q3 2026
- IMC-Chicago, LLC 3.07M sh · $590.92M · Q3 2026
- Theleme Partners LLP 8.06M sh · $564.27M · Q2 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- a16z Perennial Management, L.P. 1.52M sh · $292.57M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $161.64M · Q2 2026
- Lingotto Investment Management LLP 749.21K sh · $144.27M · Q3 2026
- Baron Funds 1.99M sh · $139.32M · Q2 2026
More on Capital World Investors
FAQ
How long has Capital World Investors held MRNA?
Capital World Investors has disclosed MRNA holdings in 8 of the last 13 reported quarters, going back to Q3 2023.
What is Capital World Investors's current position in MRNA?
As of Q3 2026, Capital World Investors holds 22.64M shares of MRNA (MODERNA INC), valued at $4.36B, representing 0.53% of its reported portfolio and ranking #47.
Has Capital World Investors been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Capital World Investors increased its position in MRNA. The position peaked in Q3 2026 at 22.64M shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Baillie Gifford & Co, IMC-Chicago, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.